SMS Pharmaceuticals post Q2 FY26 consolidated PAT at Rs. 25.31 Cr

SMS Pharmaceuticals post Q2 FY26 consolidated PAT at Rs. 25.31 Cr

By: IPP Bureau

Last updated : November 09, 2025 8:41 pm



SMS Pharmaceuticals has reported total income of Rs. 243.86 crore during the period ended September 30, 2025


SMS Pharmaceuticals Limited has reported consolidated financial results for the period ended September 30, 2025.

SMS Pharmaceuticals has posted net profit of Rs. 25.31 crore for the period ended September 30, 2025 as against net profit of Rs. 20.49 crore for the period ended June 30, 2025.  The company posted net profit of Rs. 14.09 crore for the period ended September 30, 2024.

SMS Pharmaceuticals has reported total income of Rs. 243.86 crore during the period ended September 30, 2025 as compared to Rs. 196.64 crore during the period ended June 30, 2025. The company reported total income of Rs. 198.05 crore during the period ended September 30, 2024.

For the Half Year ended September30, 2025, SMS Pharmaceuticals has reported total income of Rs .440.50 crore as compared to Rs. 363.87 crore during the 6 months period ended September 30, 2024.

The company has posted net profit of Rs. 45.80 crore for the 6 months period ended September 30, 2025 as against net profit of Rs. 30.57 crore for the 6 months period ended September 30, 2024.

SMS Pharmaceuticals Limited

First Published : November 09, 2025 12:00 am